Written by Daniel Carter,

Healthcare keeps moving. New treatments arrive. Clinical guidance changes. Familiar therapies gain new uses. Peptides are part of this shift. Nearly 100 peptide medicines have now received approval worldwide. Insulin remains the best-known example. However, peptide therapy now reaches far beyond diabetes. Some medicines support cancer care. Others help manage pain. Peptides also play roles in bone health. They can support rare disease treatment and diagnostic imaging.

Why should healthcare professionals pay attention? Simple. Peptide research may affect prescribing and monitoring. It may also shape administration and patient education. Advanced chemistry training is not required. Still, professionals need a clear understanding of the evidence. In a changing field, continuing education matters. It helps clinicians recognize new benefits, risks, and limitations.

How are peptide medicines used across healthcare?

Peptides are short chains of amino acids. Proteins also contain amino acids. However, proteins are usually larger. They are also more complex.

Many natural peptides act as hormones. Others work as chemical messengers. Therapeutic peptides can copy these natural actions. Some block them. Others change a biological pathway’s response.

By 2022, more than 80 peptide medicines had entered global markets. Another 170 remained in clinical development. Global sales had passed $70 billion by 2019 (Wang et al., 2022).

Their clinical uses vary widely. Examples include:

• Exenatide for type 2 diabetes care
• Teriparatide for osteoporosis
• Teduglutide for short bowel syndrome
• Ziconotide for severe chronic pain

Other medicines serve different specialties. Enfuvirtide blocks HIV-1 entry into cells. Lutetium-177 dotatate targets certain neuroendocrine tumors.

These examples show an important point. Peptide treatment is not limited to one specialty. It can affect medication reviews in many clinical settings.

Healthcare professionals may encounter these medicines during routine care. A nurse may manage administration. A pharmacist may review interactions or storage. A case manager may coordinate follow-up care. Basic peptide knowledge can therefore improve team communication.

How is better design changing peptide drug development?

Peptide research once relied on slower laboratory methods. Modern design has changed that process. Solid-phase peptide synthesis is one major advance. It lets researchers build amino acid chains in sequence. The process is carefully controlled. Robert Bruce Merrifield developed the method while researching peptides. His work later earned the 1984 Nobel Prize in Chemistry.

Automation has improved the process further. Modern systems can increase speed. They can also improve accuracy and consistency. Researchers can now screen large peptide libraries. Each library may contain many possible candidates.

Small structural changes can also make a difference. One amino acid change may improve stability. It may also strengthen biological activity. Healthcare professionals can better assess treatment effects by understanding them at a practical level. Cyclization can make a peptide more rigid. Fatty-acid attachment may extend its activity. Liraglutide provides a clear example. It contains a C16 fatty-acid chain. A glutamic acid spacer connects the chain to the peptide. The result is longer activity (Wang et al., 2022).

These modifications affect more than laboratory performance. They may change dosing intervals. They can influence storage needs and treatment adherence. They may also affect how adverse reactions develop. Promising? Yes. Even so, every candidate needs careful clinical testing. Successful molecular design does not guarantee a useful medicine.

How is artificial intelligence changing peptide discovery?

Artificial intelligence can review huge amounts of peptide data. It can compare sequences and structures. It can also assess electrical charges. Possible target interactions can be studied too.

What can that achieve? Faster screening.

Some systems estimate binding strength. Others predict:

• Toxicity
• Solubility
• Stability

Certain models can also create new peptide sequences. These sequences follow selected research goals. This process may help teams reject weaker candidates sooner. It may also reduce early development costs.

However, AI predictions are not clinical proof. Every model depends on its training data. Incomplete data can produce weak results. Biased datasets may create misleading patterns. An algorithm may identify a promising structure. However, it cannot prove that the structure will help patients.

Laboratory testing remains essential. Animal studies may follow. Human trials must then confirm:

• Dosing
• Safety
• Effectiveness

AI can support discovery. It cannot replace evidence. Similar concerns shape the use of AI diagnostic tools across healthcare.

Healthcare professionals should keep this difference clear. Early research can sound impressive. However, it may still be far from clinical use.

Careful interpretation becomes especially important in public media. Patients may confuse computational promise with an available treatment.

Why is peptide delivery still so difficult?

Peptides often break down quickly inside the body. Digestive enzymes may damage them before absorption. Their size can also restrict movement across cell membranes. Electrical charge may create another barrier.

As a result, many peptide medicines still rely on injections (Xiao et al., 2025).

Researchers are studying other routes. Options include:

• Nasal systems
• Transdermal systems
• Oral formulations
• Extended-release formulations

Can oral peptide treatment work? Sometimes. Even then, absorption may remain low or inconsistent.

A formulation must protect the peptide during digestion. It must also support movement through the intestinal wall.

These challenges explain an important problem. A promising peptide may still lack a practical delivery method.

Delivery affects several areas of care:

• Comfort
• Storage
• Adherence
• Dosing frequency
• Staff training

A new formulation may change the entire patient conversation. For example, extended release may reduce dosing frequency. However, it may create new storage needs. It may also require different monitoring.

Healthcare teams need to understand these tradeoffs. Only then can they advise patients clearly.

What are the main benefits and limits of peptide medicines?

Peptides attract attention because they can bind targets precisely. Their structures can also cover larger protein surfaces. Many small-molecule drugs cover smaller areas. That difference may matter clinically. Protein interactions may involve areas between 1,500 and 3,000 square angstroms. Small molecules often cover only 300 to 1,000 square angstroms (Wang et al., 2022).

This larger contact area may help peptides influence difficult protein interactions. Still, precision does not remove every limitation. Some peptides break down quickly. Others cannot cross cell membranes well.

Structural modification may also change their performance. Therefore, treatment benefits must be considered with practical barriers.

Certain products may require:

• Refrigeration
• Sterile preparation
• Injection training

Safety also differs between products. GLP-1 receptor agonists commonly cause gastrointestinal effects.

Ziconotide requires intrathecal administration. It also needs neurological monitoring.

Is there one general peptide safety profile? No. Each product needs its own assessment.

That review should consider:

• Its mechanism
• Its delivery method
• Its clinical evidence

Patient factors matter too. Kidney function may influence decisions. Liver function can also affect care. Other medicines require consideration. The patient’s treatment goals also matter. Healthcare professionals should avoid broad claims about peptide safety. Evidence for one product cannot automatically support another.

How could targeted peptide therapies change future care?

Peptides can help direct treatment toward selected receptors. They may carry:

• Medicines
• Imaging agents
• Radioactive materials

Peptide-drug conjugates use this approach. They combine a targeting peptide with another treatment. Researchers are studying these systems extensively in cancer care. The DCTPep cancer database contained 6,214 peptide-related entries in 2024 (Sun et al., 2024).

Those records covered:

• Approved therapies
• Clinical candidates
• Experimental sequences

Cell-penetrating peptides offer another approach. They may carry drugs into cells.

Some can transport genetic material. Others may carry nanoparticles. However, reliable tissue targeting remains difficult.

Peptides already support diagnosis too. Gallium-68 dotatate can identify certain neuroendocrine tumors. Lutetium-177 dotatate can then target the same receptor system. This pairing may improve patient selection. It may also support more focused treatment. This relationship combines diagnosis and therapy. It can show whether a tumor expresses the relevant receptor. Treatment may then target that same feature. However, these approaches need specialist imaging. They also require careful patient selection and coordinated follow-up.

How can regulatory knowledge protect patients?

Not every peptide product has the same regulatory status. That difference matters.

FDA-approved drugs undergo formal review. Regulators assess:

• Safety
• Effectiveness
• Manufacturing quality

Investigational products follow another path. They remain within regulated research programs.

Compounded preparations follow separate requirements. However, they do not receive standard FDA premarket approval.

Some products carry the label “research use only.” These products are not approved for patient treatment.

Can online availability prove safety? No. A product may look professional. Yet it may lack dependable clinical evidence.

Healthcare professionals should first identify the exact product. They should also confirm the manufacturer.

Next, they should review:

• The intended use
• The dose
• The regulatory status

Trial evidence deserves equal attention. Important details include:

• Study phase
• Participant numbers
• Follow-up periods
• Adverse events
• Study endpoints

These decisions involve professional responsibility. Therefore, legal ethics in healthcare remain relevant. They matter when clinicians assess uncertain or unapproved products.

The FDA has highlighted several peptide-specific concerns:

• Liver impairment
• Drug interactions
• QTc prolongation
• Immunogenicity

These concerns do not apply equally to every product. However, they show why each therapy needs specific evaluation.

Regulatory awareness helps clinicians avoid unsupported assumptions. It also supports clearer documentation. Informed consent may become safer too (U.S. Food and Drug Administration, 2023).

How can peptide knowledge improve patient conversations?

Patients now encounter peptide claims in many places. Sources include:

• Clinics
• Social media
• Product websites
• Online sellers

Some promotions use appealing terms:

• “Recovery”
• “Wellness”
• “Healthy aging”

These phrases may sound reassuring. However, they do not prove safety or effectiveness. Healthcare professionals need enough detail to explain the difference. Semaglutide has approved indications. It also has standardized formulations. Clinical trial data support its regulated uses.

A research chemical bought online may offer none of those protections.

Medication reviews should include:

• Injections
• Compounded products
• Online purchases

Clinicians should record:

• The product name
• The dose
• The source
• The patient’s treatment goal

In practice, careful medication planning for patients can reveal duplication. It can also identify unsafe combinations or unclear goals.

Teams should watch for duplicate therapies. Similar products may affect the same receptors.

Clear communication can reduce confusion. It may improve monitoring. It can also prevent avoidable harm. Professionals should explain what is known. They should also explain what remains uncertain. Product quality matters too. This approach respects patient interest. It does not validate unsupported claims. These conversations may involve several healthcare roles. Pharmacists can review formulations and interactions. Nurses may identify administration problems. Case managers may notice access or adherence barriers. Shared information helps the entire team respond consistently.

Why does staying current matter for responsible care?

Peptide medicines already influence many areas of healthcare. They support diabetes treatment. They also help with cancer imaging. Some products support pain management. Others address bone loss or rare diseases. Meanwhile, the field keeps expanding. New delivery systems are emerging. AI tools are supporting discovery. Targeted therapies are also becoming more advanced. Understanding advances in peptide science supports stronger clinical judgment. It helps professionals interpret new evidence. It also helps them avoid overstating findings. Current knowledge supports safer monitoring. It also leads to clearer patient conversations.

Author bio

Daniel Carter is a health and science writer. He covers clinical research, medical innovation, and patient education. His work makes complex healthcare topics clear for professional audiences. Outside of writing, Daniel enjoys hiking, reading history, and cooking for family and friends.

References

American Institute of Health Care Professionals. (2024, March 14). Case manager’s role in medication planning for patients. https://aihcp.net/2024/03/14/case-managers-role-in-medication-planning-for-patients/

American Institute of Health Care Professionals. (2025, January 10). The role of legal ethics in healthcare. https://aihcp.net/2025/01/10/the-role-of-legal-ethics-in-healthcare/

American Institute of Health Care Professionals. (2025, February 25). Lifelong learning in healthcare: Why continuing education matters. https://aihcp.net/2025/02/25/lifelong-learning-in-healthcare-why-continuing-education-matters/

American Institute of Health Care Professionals. (2025, July 1). Emerging trends in AI diagnostic tools shaping the future of accessible healthcare. https://aihcp.net/2025/07/01/emerging-trends-in-ai-diagnostic-tools-shaping-the-future-of-accessible-healthcare/

Sun, X., Liu, Y., Ma, T., Zhu, N., Lao, X., et al. (2024). DCTPep, the data of cancer therapy peptides. Scientific Data, 11, Article 541. https://doi.org/10.1038/s41597-024-03388-9

U.S. Food and Drug Administration. (2023, December). Clinical pharmacology considerations for peptide drug products: Draft guidance for industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-pharmacology-considerations-peptide-drug-products

Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: Current applications and future directions. Signal Transduction and Targeted Therapy, 7, Article 48. https://doi.org/10.1038/s41392-022-00904-4

Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025). Advance in peptide-based drug development: Delivery platforms, therapeutics and vaccines. Signal Transduction and Targeted Therapy, 10, Article 74. https://doi.org/10.1038/s41392-024-02107-5

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Isaac Smith

A physician spends over a decade training to treat patients, not to process claims. She opens a multi-specialty practice with an in-house lab, the one she’s proudest of, the one that was supposed to be the easy win. Six months in, she’s on hold with a payer on a Saturday morning instead of at her kid’s soccer game. Again.

The lab was supposed to be the easy win. Faster results, better continuity of care, one less referral to chase down. Nobody warned her that lab claims come with their own dense rulebook: bundled panels, frequency limits, medical necessity documentation that has to match almost exactly what the payer expects to see. Get one piece wrong and the whole claim bounces back.

This isn’t really a story about one doctor. It’s the story of almost every clinician who’s ever tried to run a practice.

Nobody Trains You for This Part

Nursing school teaches you to read a chart. Case Management Certification teaches you to coordinate care across a dozen moving pieces at once. Counseling programs teach empathy, boundaries, and clinical judgment. None of it, not one hour of it, in most programs covers what happens after the visit ends, once the claim gets submitted and somebody, somewhere, decides whether it gets paid.

That gap is forgivable in a classroom. It’s a lot less forgivable once real patients are involved. A denied claim isn’t just an accounting headache. It can hold up a follow-up test a patient actually needs. A credentialing application stuck in review for eight weeks means a new provider is sitting there fully licensed, willing to work, and unable to see anyone because the paperwork with a payer hasn’t cleared yet. It happens more often than people outside of billing tend to realize.

Where Things Go Wrong, and Why Lab Claims Are Their Own Animal

Most denials aren’t about bad medicine. They’re about a missing modifier. An eligibility checks nobody ran before the appointment. A diagnosis code that’s close but not quite what the payer wanted.

Lab billing takes all of that and multiplies it. There’s a reason so many practices that run their own labs, or order a high volume of diagnostic testing, end up looking at outsourced lab billing services instead of trying to build that expertise in-house — the rules shift often enough, and the denial rate on lab claims handled by a generalist billing team tends to run noticeably higher than routine office visit claims. It’s a narrow enough specialty that most practices are better off bringing in people who already live in it every day, rather than learning it the expensive way, one denied claim at a time.

Denial management itself is often treated as a one-off task rather than an actual process. Someone clears today’s stack of denials and moves on to the next fire. Nobody goes back and asks why the same error keeps showing up month after month. That’s usually where the real money quietly leaks out, and where practices lose the most without ever quite noticing it.

Why Clinicians Should Care About Any of This

Nobody’s saying a nurse practitioner needs to learn CPT coding cold, or that a case manager should be reading payer contracts for fun on a Friday night. But understanding just enough to know when something’s off is a different skill entirely, and it’s one that actually protects patients.

The practices that hold onto good staff, and that don’t lose patients to administrative delays, tend to share one thing in common: someone is paying attention to this side of the operation before it turns into a five-alarm fire. Sometimes that’s the physician herself, squeezing it in between patients. More often, it’s a billing partner who’s already seen the same problem a hundred times before and knows exactly where it’s headed.

Credentialing: The Quiet Bottleneck

It’s worth pausing on credentialing specifically, because it’s easy to underestimate. A practice hires a great new provider, expects them to start seeing patients right away, and doesn’t realize that payer credentialing can take anywhere from a few weeks to several months depending on the plan. In the meantime, that provider is either sitting underused, or the practice starts billing under someone else’s name and creates a compliance headache down the road. Getting ahead of credentialing early, before the hire even starts, saves more revenue than most practices realize until they’ve lived through the alternative.

The Bottom Line

Clinical skill is what gets a patient through the door. Whether they keep coming back, whether the provider who treated them actually gets paid on time, whether the practice is even still standing a year from now, depends on something a lot less visible than the chart itself.

If you’ve lived this, as a provider, a case manager, or whoever ends up fielding the billing calls nobody else wants to take, you already know it’s real. It’s one of the most overlooked pieces of whether good care actually reaches the people who need it, when they need it most.

Author Bio: Isaac Smith is a revenue cycle management (RCM) content writer with a background in journalism and a passion for healthcare and finance. With over a decade of experience creating informative and engaging content, he specializes in topics related to medical billing, coding, revenue cycle management, compliance, reimbursement trends, healthcare technology, and financial optimization. As a content writer at Manifest Technology Solutions, a leading medical billing and RCM services company, Issac develops insightful content that helps healthcare providers, medical practices, and billing professionals navigate the evolving healthcare landscape. His goal is to simplify complex industry concepts, share practical strategies, and support organizations in improving operational efficiency and financial performance.

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Marchelle Abrahams

Interruptions to addiction treatment could make it harder to recover. No one knows this better than case manager Annette Hubbard. Working at a local community clinic in Alaska, she’s seen thousands of patients come and go.

The majority of her clients are in and out of prison. They are the most vulnerable to drug-related deaths. Hubbard routinely checks the court docket for active warrants. She helps those with opioid use disorder get treatment before they go in. 

Hubbard tells NRP that she does it voluntarily, even though it’s outside her scope of work. Because she knows that addiction doesn’t happen in a vacuum. Neither does recovery.

If you’re a case manager, you already know this. A treatment plan can look perfect on paper and fail in the real world. Why? Simple. Social determinants of health (SDOH) influence outcomes long before a client walks through your door.

This guide breaks it down in plain terms: what SDOH means in addiction care, where case managers fit in, and how to turn awareness into action.

What Are Social Determinants of Health? 

These are the conditions in which people live. Work in. Move through everyday life. Housing, income, education, access to care, and social support; these are all SDOH.

These factors have a bigger impact on health outcomes than medical care alone. That’s not a small claim. It reshapes how we think about addiction treatment, explains the CDC.

The Healthy People 2030 framework groups SDOH into five key areas:

• Economic stability
• Education access and quality
• Healthcare access and quality
• Neighborhood and built environment
• Social and community context

Case managers view the above as daily barriers.

How SDOH Fits into Addiction Care

Substance use disorders (SUDs) are linked to life conditions. Housing instability. Unemployment. Trauma. Lack of access to care. They all raise risk.

The American Journal of Psychiatry published a paper earlier this year. The piece explored the intersection between the Diagnostic and Statistical Manual of Mental Disorders (DSM) and SCE-DoH.

Researchers found that:

• People without stable housing struggle to stay in treatment.
• Limited income restricts admission for ongoing care.
• Social isolation increases relapse risk.
• Poor access to services delays intervention.

The National Academy of Medicine supports these outcomes and has called for a move towards integrated systems that address clinical care and social needs. In other words, treat the person, not only the addiction.

The Case Manager’s Role

Case managers sit at the crossroads of addiction and recovery care. Clinical teams, social services, families, and community resources all run through you.

Effective case management improves engagement, continuity of care, and long-term outcomes. And it goes beyond paperwork and scheduling. It’s your job to identify social barriers, connect clients to resources, and advocate across networks.

Think of it this way: clinicians stabilize. Case managers sustain.

Breaking Down Key Social Determinants

Housing Stability

Housing is one of the strongest predictors of recovery success. Back in 2024, Delaware’s Department of Health and Social Services put the hypothesis into practice.

Homelessness is common for those struggling with addiction, said Joanna Champney, director of the Division of Substance Abuse and Mental Health. 

“Reports from our behavioral health treatment providers indicate that when people enter mental health treatment in Delaware, 13% were totally homeless at admission. For people entering addiction treatment in Delaware, 7% were totally homeless.” – Joanna Champney via WHYY.

Using 2023 data, Champney reported that 67% of clients receiving services through the federal Statewide Opioid Response Grant experienced housing instability. The DHSS then initiated the Recovery Support Scholarship program, allowing treatment centers to provide housing support for patients.

As a case manager, you can:

• Prioritize housing referrals early
• Work with transitional housing programs
• Build relationships with local shelters and housing services

Economic Stability

Treatments cost money. So does time off work. Unfortunately, not all rehab facilities accept Medicaid coverage. 

New Mexico’s Albuquerque is rife with fentanyl addiction. The city’s Bernalillo County Metropolitan Detention Center is currently struggling with inmates battling drug addiction. Most are forced to detox while in prison.

Fentanyl remains the top drug threat in the area, particularly among young people, claims the DEA. Albuquerque programs that take Medicaid plans are a lifeline for residents. 

Medicaid-covered rehab can open doors to detox, in-patient, and out-patient care. Financial stress is a relapse trigger. Reducing it is part of the treatment. 

Albuquerque Medicaid treatment programs provide essential support for individuals who cannot afford private insurance, adds Icarus Recovery Center. Focus on:

• Verifying insurance early
• Educating clients on coverage
• Identifying low-cost or no-cost options

Healthcare Access

Access is not having a clinic nearby. It entails getting in, staying in, and being treated.

And yet, the National Library of Medicine says that gaps in care remain an issue. It disrupts recovery during the transition period. Once again, this is where you step in.

Case managers should prioritize coordinating appointments across providers, reducing wait times where possible, and supporting follow-ups.

Social Support and Community

Recovery is hard to sustain.

Isolation and loneliness can trigger relapse. Support networks improve outcomes; it’s that simple.

Research published in Frontiers in Rehabilitation Science supports the suggestion of community integration in long-term recovery.

What works?

• Peer support groups
• Family engagement
• Community-based recovery programs

Common Gaps Case Managers Should Be Aware Of

Even experienced professionals tend to miss a few things. Here are a few to keep on your radar:

• Transportation gaps: Missed appointments can trace back to travel issues
• Digital access: Telehealth fails without stable internet or devices
• Childcare needs: Specifically in outpatient settings
• Legal issues: Court dates and compliance requirements disrupt care

None of these sit inside treatment plans. But they do determine outcomes.

FAQs

1. Why are social determinants important in addiction recovery?

They directly affect whether someone can start, continue, and complete treatment. Clinical care alone isn’t enough.

2. What is the most critical SDOH in addiction care?

Housing is the biggest factor. Without stability, recovery outcomes drop substantially.

3. How can case managers improve access to care?

By coordinating services, reducing barriers such as cost and transport, and connecting clients to community resources.

4. Do Medicaid programs improve treatment outcomes?

Yes. They expand access to care for low-income individuals, making treatment more consistent and achievable.

Key Stats on SDOH and Addiction Care 

From Awareness to Action

Understanding SDOH is the first step. Acting on them is where you’ll make the biggest impact.

Ask better intake questions. Map local resources. Track barriers over time. Advocate for system-level changes.

You don’t need to fix everything, but you do need to notice everything. And that’s the difference.

Author bio:

Writer by day, dream catcher by night. Marchelle Abrahams cut her teeth during the infancy of the internet when the dial sound of the modem was more than a soundbite at a rave. Not a Millennial and not a Boomer, Marchelle is an in-betweener, making her a special breed of human. As a qualified journalist, Marchelle believes her superpower is stringing a few words together and people reading them. That, and the ability to take her kids on with her unique brand of gnarly comebacks.

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Deboshree Bhattacharjee,

Health problems can be frustrating enough, but they somehow feel worse when we realize we could have prevented them. We could have taken steps to avoid falling prey to ailments that now require long-term management.

The world’s chronic disease burden can be distressing. The Peterson KFF tracker reports that chronic diseases are a leading cause of death. Whether it is hypertension, kidney disease, or chronic obstructive pulmonary disease (COPD), they continue to affect people despite advancements in medical treatment.

In the US, these conditions comprise 80% of the primary causes of death. While not all conditions are preventable, several connect directly to physical inactivity and substance abuse. 

Nursing professionals can play a significant role in transforming this state of affairs, provided they have a community and regulatory support system.

Recommending and Supporting Patients Through Preventive Steps

The most impactful intervention for avoiding chronic disease is to recognize the possibility of it developing from an early stage in a person’s life. Nurses, who may interact with patients across their lifespan, can deliver tailored recommendations that can improve health outcomes.

For example, a 2024 study in the European Respiratory Review explains that COPD does not always develop in adulthood due to smoking or pollution exposure. The scholars assert that this chronic disease is also connected to early respiratory infections and poor nutrition. 

“It has been proposed that COPD (and many other chronic diseases) results from different dynamic and cumulative gene–environment interactions occurring over the lifetime of the individual.” – Rosa Faner et al., Researcher, European Respiratory Review.

This makes it crucial to study early-life influences and take the necessary steps to reduce the risk of developing the illness. Even for conditions like cancer, timely interventions may lower an individual’s risk to some extent. This is especially true for obesity-related cancers. 

A British Journal of Cancer study notes that large-scale weight management may be able to prevent such cancers. GLP-1 agonists (glucagon-like-peptide) have been found to be a potent pharmacotherapy approach for managing obesity. Lifestyle-based interventions, such as dietary and exercise changes, can also be supporting agents.

Nurses can recommend data-backed preventive approaches for chronic illness and help patients follow through on them. This requires a deeper and more intimate relationship with a patient than a physician may be able to build or have the time for. A nurse’s focus on active listening and empathy is essential.

Steering Patient-Centric Research Based on Behavioral Cues

Another far-reaching way nursing practitioners can impact public health is through research that is genuinely patient-centered. In both inpatient and outpatient settings, nurses have the opportunity to observe patients closely. Behavioral cues can reveal a great deal about how a patient is coping with a condition and whether they are adhering to their medication.

Consistency and proactive caution are vital in preventing and managing chronic disease. In 2024, a research study in the International Journal of General Medicine found that narrative nursing decreased the negative emotions perceived by patients with digestive tract cancers. The core tenets of such nursing include understanding patients’ conditions and needs through their own narratives to deliver personalized care.

Working professionals who pursue a Doctor of Nursing Practice online can learn to apply scientific inquiry and technology to conduct further research in these areas. At the same time, they can continue to fulfill their current roles and remain connected to ground-level patient care.

According to Wilkes University, developing leadership skills to advance nursing practice is a strong step toward applying research to solve global health problems. This strategy equips you to shape the regulatory and policy framework while contributing insightfully with patient behavioral cues. 

Extending Patient Care Through Telehealth and Virtual Means

For nurses, maintaining continuity of care is paramount. It ensures that people with chronic illness or those at risk of developing it have support and guidance. Unfortunately, many people in remote and rural areas lack reliable access to healthcare. This increases their risk of developing chronic ailments.

Telehealth and digitally administered care can fill this gap. Regular sessions help nurses look for warning signs and recommend immediate action. 

For example, physically restricting conditions such as arthritis can often impact mental health. Individuals who feel disconnected from their peers and family members can experience isolation and loneliness. 

It does not bode well for those with a greater risk of developing depression, another chronic illness. A 2026 Gallup poll finds that more than 19% of US adults report having or receiving treatment for depression. This translates to roughly 51 million Americans. Nurses who track patients’ health over time can notice early signs of a depressive episode, such as tiredness and mood swings. 

It is heartening that alternative models of nursing care are becoming popular. It can bring substantial improvements in dealing with chronic illnesses among people who find in-person care difficult due to various reasons. Cost, travel, and social stigma are notable factors that virtual care can address.

FAQs

1. How can nurses help prevent chronic ailments?

Nurses can play a crucial role in preventing chronic disease by educating patients about healthy lifestyles and encouraging regular screenings. They can also monitor early warning signs and support long-term behavior changes. This personalized care and ongoing communication can help patients reduce risks associated with conditions such as diabetes, heart disease, and COPD.

2. Why is telehealth important in managing chronic diseases?

Telehealth can improve access to healthcare for patients in rural and remote communities. Through virtual consultations, nurses can monitor symptoms, provide follow-up care, and encourage adherence to medication. They can identify early signs of mental health concerns. Continuity of care enhances long-term health outcomes for people with chronic illnesses.

3. What role does patient-centered research play in limiting the chronic disease burden?

Patient-centered research allows healthcare professionals to understand how individuals experience chronic illnesses and respond to treatment plans. During patient interactions, nurses can observe behavioral patterns, emotional responses, and roadblocks to medication adherence. These insights can guide more personalized interventions and improve healthcare delivery. Over time, a research-focused approach can support policies for managing chronic diseases.

Nursing and the Global Chronic Disease Burden

Unburdening the World From Chronic Disease

The chronic disease burden remains a challenge for healthcare workers and policymakers all over the world. Evolving medical technologies have addressed some of the risk factors, making advanced treatment possible. However, nursing support is imperative for the smooth implementation of these changes in ways that benefit diverse patient communities.

Helping their patients through preventive steps to avoid chronic disease and actively participating in research initiatives can ease the burden. Nursing practitioners should also develop greater enthusiasm toward telehealth and digital care roles. These will be necessary to expand the ambit of care for underserved populations, who may also be more susceptible to chronic illness.

References:

Imani Telesford, Matthew McGough, Delaney Tevis, and Lynne Cotter   (2025). How has the burden of chronic diseases in the U.S. and peer nations changed over time? Retrieved from Peterson-KFF Health System Tracker

Rosa Faner, Michael H. Cho, and Gerard H. Koppelman (2024). Towards early detection and disease interception of COPD across the lifespan. Retrieved from European Respiratory Review

Harris, M., Brown, J. & Renehan, A.G. Preventing obesity-related cancer with the revolution in obesity management: the challenges of undertaking a clinical trial and potential solutions. British Journal of Cancer. Retrieved from BJC.

Zhng, Y. (2024). Effect of Narrative Nursing Intervention on Patients with Specific Digestive Tract Malignancies (Esophageal, Gastric, and Intestinal Cancers): A Retrospective Study. International Journal of General Medicine. Retrieved from Taylor and Francis.

Doctor of Nursing Practice (DNP) Program (2026). Wilkes University. Retrieved from the Wilkes University website.

Dan Witters (2026). U.S. Depression Rate Remains Elevated. Gallup. Retrieved from the Gallup website.

Author Bio:

Deboshree Bhattacharjee likes telling stories that delight and engage. Her focus areas include lifestyle, parenting, health & wellness, and technology. Besides writing, she also edits and strategizes content. Every morning, she wakes up with the northern lights in her eyes and chalks out travel plans.

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Deboshree Bhattacharjee

The pace of evolution in healthcare is impressive. We have moved on from standard treatments for everyone to precise care that perseveres to reach the root of the problem. In nursing, new models of care have emerged to improve patient health over their lifespan. Genomics is one of these advanced techniques: it may sound complex, but it has actually started delivering excellent results.

Essentially, this methodology of diagnosis and care takes the genetic makeup into close consideration. After all, diverse populations may respond to similar care strategies differently based on multiple factors, including lifestyle and sociocultural parameters. Genes, which affect many underlying bodily aspects, occupy a prominent space among these factors.

The Human Genome Project has been one of the most significant biomedical research projects of our time. As early as 2003, this project produced a genome sequence that covered 90 percent of the human genome. Since then, genomic data has proved immensely helpful in biomedical advancements and healthcare. 

As a nursing practitioner, integrating genomic insights into your care models can be transformational.

Assess The Possibility of Hereditary Conditions

We live in such challenging times, so fraught with risks of microbial contamination and lifestyle-induced sickness, that hereditary possibilities don’t seem as likely. Many professionals restrict this category of diseases to relatively rare concerns like cystic fibrosis and sickle cell anemia. 

However, several recent studies have indicated that seemingly “regular” cardiac and blood pressure problems could also be affected by genetic makeup. Sidestepping this aspect in diagnosis and treatment can lead to suboptimal outcomes.

In 2025, a research study published in Nature Communications showed that cardiovascular diseases often co-occur with genetic correlations. Many of these complex conditions have a shared genetic basis. Studying and applying the underlying biological mechanisms behind clinically defined cardiovascular diseases can ensure that patient care is focused and informed.

As a nurse, you are uniquely positioned to identify such possibilities because you have an ongoing relationship with the patient. Your interactions focus on communication and active listening, which makes it likely that you can pick up on cues like:

• Breast cancer incidence in the family
• A history of cardiac troubles and unhealthy eating habits
• Recommended genetic testing for another condition, which the patient may not find relevant to disclose to a physician or in an intake form

Based on your observations, you can recommend earlier screenings and lifestyle interventions. These can potentially be life-altering for patients with genetic risks. You will also be a reliable source of actionable steps people can take, which has become imperative in this age of mistrust.

“We find ourselves in a time where fake news, lies, conspiracy theories, misinformation and disinformation are rampant.” – Dr Tedros, WHO Director-General

Monitor and Advise on Drug Dosage Based on Genetic Metabolism

Helping patients understand and follow their medication regimen has always been a core nursing responsibility. 

Medication adherence can be particularly tricky in older adults, who may display inappropriate use or struggle to follow multiple pharmacological regimens. Some patients discontinue their dosage if they don’t perceive significant benefits. This can be alarming for chronic conditions that demand continued medication. 

A 2024 Cureus study on medication adherence in the Middle East showed that asthma patients had only 41% rate of adherence. They also had higher levels of severe depression. Patients with schizophrenia are also known to show poor adherence, partly due to side effects and because they feel uncomfortable with the treatment.  

What if the reason behind a medication’s apparent inefficacy or a patient’s adverse reaction to it lies in genomic data?

The American Council on Science and Health explains that genetic testing can reduce side effects for patients who need psychiatric and cardiovascular drugs. This is because drug metabolism can be affected by our genetic makeup. 

No wonder more healthcare firms are investing in using advanced technologies to fine-tune drug dosage. Pharmacogenomics promises to usher in groundbreaking changes in how nurses can support patients with their drug regimens. 

Equip Yourself With an Advanced Academic Foundation

With genomics now accessible to healthcare organizations, nursing professionals are learning to apply these insights. 

Incorporating deeper, more personalized learning into everyday practice can support patients like never before. Not only do they benefit from prescribed drugs with lower side effects, but they also adopt a more considered lifestyle. Early cancer screenings or lipid profile testing become standard for those at risk, possibly averting a chronic disease that could have been.

As a working nurse, pursuing an FNP degree online can be a smart way to equip yourself with advanced health assessment competencies. It can train you to integrate genomics and apply biopsychosocial principles in your practice.

It also accrues considerable career advantages, including higher salaries for more advanced responsibilities. You may also find opportunities to be part of multi-specialty patient care teams for serious illnesses such as cancer.

While selecting a further education path, ensure it aligns with your current work and personal routines. American International College recommends seeking accreditation with CCNE, the Commission on Collegiate Nursing Education, and a flexible delivery format.

With these skills to guide you, your patients will benefit from personalized and more accurate medication. You can also use genomic insights to complement prescription digital therapeutics. Some practitioners are trying out this comprehensive approach as part of biopsychosocial treatment for schizophrenia (and other conditions).

FAQs

1. How is genomics used in contemporary nursing practice?

Genomics can help nurses understand a patient’s genetic makeup and how it influences their disease risk and treatment response. Nurses can use these insights to recommend earlier screenings and personalized care plans. On the whole, it facilitates better patient education for serious conditions such as cancer and mental health disorders.

2. Should nurses learn about pharmacogenomics?

Yes. Pharmacogenomics can help nursing professionals understand how genes affect a patient’s response to medicines. These insights can help nurses monitor side effects and streamline treatment routines. This way, they can contribute to more personalized treatment plans that enhance patient results.

3. How can an online FNP degree help nurses acquire genomics competencies?

An online FNP degree can help nurses build advanced assessment, diagnostic, and patient care skills. Such programs may introduce students to evidence-based practices, including genomics and personalized healthcare. The online format supports flexible scheduling for working professionals.

Patient Health and Genomics By The Numbers

Genomics Can Enable More Informed Patient Care

Amid all the mad rush for the next AI application that creates simulated worlds and volatile social media trends, it is heartening to see healthcare advancements progressing well. They may not always make front-page news, but the changes that tailored care is bringing are meaningful and enduring.

For nurses, learning about genomics and finding the confidence to go the extra mile in their practice can be a huge career step. Imagine the difference one could make by employing individual data to develop more effective medication and preventive techniques. 

Moreover, you will ensure that people do their part in following instructions, all through nursing superpowers of understanding and assistance.

References:

Human Genome Project (2026). Retrieved from the National Human Genome Research Institute website.

Qiao, J., Jiang, L., Cai, L. et al. (2025). Shared genetic architecture contributes to risk of major cardiovascular diseases. Retrieved from Nature Communications. 

WHO looks back at 2024 (2024). Retrieved from the WHO website.

Cardona D, Santacruz-Restrepo V, Rendón-Montoya A, Madrigal-Cadavid J, Segura-Cardona A and Estrada-Acevedo JI (2025). Medication adherence in the elderly population with chronic diseases: a factor analysis. Retrieved from Frontiers.

Alomar A O, Khushaim R H, Al-Ghanem S K, et al. (2024). Relationship Between Depression and Medication Adherence Among Chronic Disease Patients in the Middle East. Retrieved from Springer Nature.

Henry I. Miller (2025). How Genetic Testing Could Prevent Dangerous Drug Reactions and Reduce Healthcare Costs. Retrieved from American Council on Science and Health.

American International College (2026). Online MSN – Family Nurse Practitioner (MSN-FNP). Retrieved from the American International College website.

Rimal B. Bera, MD, Ryan Haumschild, PharmD, MS, MBA, CPEL (2025). The Potential of Prescription Drug Therapeutics (PDTs) in Schizophrenia. Retrieved from AJMC.

Author Bio:

Deboshree Bhattacharjee likes telling stories that delight and engage. Her focus areas include lifestyle, parenting, health & wellness, and technology. Besides writing, she also edits and strategizes content. Every morning, she wakes up with the northern lights in her eyes and chalks out travel plans.

Please also review AIHCP’s Case Management Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Sofia Vallasciani,

“Is home really the best place?” It’s a question that triggers anxiety for both families and clinicians when care needs intensify. As a loved one ages, you and your whole family may find yourself sorting through a tangle of home care, residential care, and hybrid options. The stakes are high: quality of life, finances, and future well-being may all depend on your choice.

However, in the decision-making process, there is one ally to not overlook: your clinician. Clinicians often know your family and concerns, and may have followed your loved one through their care needs. Consulting them helps you get practical strategies for conversations and step-by-step tools for needs assessment, risk review, and budgeting. All of this can make it easier to navigate what’s ahead with more confidence, less stress, and peace of mind. 

Mapping the Conversation: Start With a Strong Foundation

Noticing that a loved one needs more help than he or she usually requires can be tough for family and friends. You may not be sure where to begin, what options are available, or what level of care may be needed at each stage. Here, clinicians can play a significant role in helping to guide the discussion with clarity and balance.

They will usually start by opening up the conversations and get a better feel of the situation with questions such as, “What matters most to you and your loved one right now?” Answering honestly and openly can help you and your family address immediate concerns and longer-term worries.

During a conversation regarding your loved one’s care, a clinician may use some strategies, including:

• Clear, jargon-free explanations of home versus facility versus hybrid care.
• Early identification of priorities (safety, independence, cost, access to medical care).
• Emotional acknowledgment. They know that families will feel vulnerable, and they will work to normalize those emotions.

It may take patience, but recognizing family emotions upfront is essential to set the foundations of honest dialog later. 

Needs Assessment: Sorting Wants, Needs, and What’s Realistic

A structured needs assessment is the first step, which will support the entire decision-making process, grounding your decisions in facts rather than fear or wishful thinking. Clinicians can guide families through core questions, including:

• What physical, cognitive, and emotional support does the person need on a daily basis?
• Which tasks are truly challenging? These may include changes that you have noticed regarding everyday activities or aspects such as medication, bathing, transportation, and meal prep.
• How available and willing are family members to pitch in, and for how long?

It is important to answer these questions honestly, allowing your clinician to have a full picture of the situation. For a fairer assessment, clinicians may also recommend using checklists, like those provided by AARP Needs Assessment, to clarify and quantify these details. 

Clinicians may also review your loved one’s medical history to identify health issues that may be manageable now but require more intensive care in the future. This way, you can have a clear idea of the steps ahead and what to expect as your loved one ages or their disease progresses. 

Weighing the Costs: Budgets, Value, and What’s Achievable

Cost is usually a key point in care discussions, and families often underestimate both the price and value of in-home support. However, it is important to understand that there are different levels of care, which are differently priced, and financial support options for eligible families. 

Here’s where consulting a healthcare provider can truly pay off. They understand the options available and the strategies you can use to reduce your out-of-pocket costs. During a thorough conversation, they will be able to take you through important aspects, such as:

• Common home care services (personal care, homemaker assistance, nursing).
• Typical price ranges by region.
• What is and isn’t covered by Medicare, Medicaid, or private insurance.

They can help you better understand what are the senior care costs and benefits to expect, providing you with a realistic price forecast and an overview of the services that are typically included.

Managing Your Emotions During Money Conversations

Discussing detailed costs also helps reduce tension over what’s affordable by identifying which options fit within the family’s budget. When everyone sees a clear comparison of services and their prices, it becomes easier to remove emotion from the decision and select practical solutions that don’t cause resentment later. If the budget remains a sticking point, a provider can help the family separate true needs from extras, ensuring the essentials remain non-negotiable. 

As much as it feels cold to assign a value to a loved one’s care, understanding costs is critical for planning support that’s sustainable. If families overextend and run out of resources, gaps in both care and health outcomes can develop. Simply, making careful, well-informed budgeting decisions is an act of love as much as duty.

Assessing Risk: Safety, Function, and Setting

Risk conversations are rarely comfortable. No one wants to discuss the day-to-day needs of a loved one or how their health and care needs may change over time. However, discussing this aspect is vital for family peace of mind. They are also essential for meeting legal and ethical standards, ensuring your loved one is cared for in an efficient, compliant, and dignified way. 

A clinician may use open questions to guide families:

• “What specific risks worry you most about home care? Are falls, wandering, or emergencies the main concern?”
• “How likely is a sudden decline, and what backup plan feels realistic?”
• “Which care setting offers the right level of supervision and structure?”

Assigning risk “tiers” (low, moderate, high) with clear examples can help families remove bias and correctly identify the level of care needed. 

A clinician might say, “If your father only needs help with occasional meal preparation but manages all medications safely, he’s at low risk and could thrive with part-time in-home support.” Or, “If your mother experiences frequent falls and sometimes forgets to turn off the stove, that places her in the high-risk category. In this case, 24-hour supervision at home may be safest.”

Using these kinds of specific scenarios frames the discussion around facts instead of fear, helping families see where their loved one truly fits on the risk spectrum. 

Navigating Family Conflict and Bias

Even with the best prep, conflict can erupt when siblings, spouses, or multiple generations get involved. Clinicians will expect, not fear, strong opinions. They understand that conflicts often start when some family members fixate on worst-case outcomes, issues relating to finances or level of responsibility, or when past grievances resurface as objections about care.

To keep things productive a clinician may:

• Use scripts: “I can see this is stressful for everyone. Can we focus on what matters most to your loved one?”
• Encourage the “wisdom of the table” by giving each participant a chance to state their concerns, without interruption.
• Normalize disagreement as a natural phase of family decision-making.
• Taking short breaks or moving the conversation to neutral territory (a coffee shop, park, or video call). 

The point isn’t to force agreement: it’s to ensure every family voice is weighed with dignity.

Documentation and Scripts: Tools for Clear, Unbiased Decisions

Accurate documentation supports better care, reduces revisiting old arguments, and ensures wishes are taken into account during the decision-making process. Clinicians can prepare take-home worksheets that include:

• Date and participants in each meeting.
• Main concerns and care goals discussed.
• A brief summary of options, ruled-in and ruled-out.

Sample scripts to aid decisions might use phrasing like:

“Based on what we’ve discussed, here are the options we’ve agreed to consider… Our next step is to revisit these choices in two weeks, unless there’s a significant change in health.”

Sharing copies for everyone (yes, even via group email) avoids miscommunication and showcases that the process is transparent, which may help avoid conflict down the line.

Exploring Hybrids: When Neither Home Nor Facility Feels “Right”

Sometimes the best option isn’t either-or, it’s both. Hybrids, such as adult day services plus in-home help, can bridge gaps for families not ready to commit fully to residential care.

Your clinician may discuss hybrid options, which are often customized around your loved one’s needs. During this conversation, your healthcare provider can bring together support from different providers, providing information such as:

• What services operate at home, in the community, or virtually.
• A sample week’s support (e.g., in-home care three mornings, adult day care twice a week).
• Reviewing transportation, supervision, and transition plans if needs change.

Clinicians may also encourage families to trial a hybrid model for 30–60 days, adjusting as needed, rather than making irreversible decisions after a single stressful meeting. During this time, you may be able to review and assess the level and quality of care, find out what works and what needs improvement, and discuss your thoughts with other family members. This can help you make a more informed decision when the time comes. 

Final Thoughts: Continuing the Family Care Conversation

Choosing between home, facility, or combination care isn’t a one-time event. Needs evolve, finances shift, and family dynamics change. Clinicians can help approach these conversations with humility, transparency, and expert tools that can help families choose with confidence.

For more practical frameworks, scripts, and case studies on family-centered care planning, The American Institute of Health Care Professionals’ internal blog archives offer a wealth of clinician-tested insights. Explore resources for continuing education, downloadable worksheets, and clinician support networks to deepen your understanding and enhance your next care conversation.

Writer Bio

Sofia Vallasciani is a health and wellness writer with over five years of experience creating clear, accurate, and accessible medical content. She specializes in translating complex health topics into reader-friendly material, with particular expertise in regenerative medicine, integrative health, and lifestyle medicine. Her work focuses on educating readers and supporting informed health decisions through evidence-based writing.

Please also review AIHCP’s Case Management Certification program and Case Management Courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification